aminolevulinic acid has been researched along with Acute Kidney Failure in 3 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-aminolevulinic acid markedly reduced renal dysfunction and tubular damage in mice with rhabdomyolysis-induced AKI." | 7.91 | 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. ( Itano, S; Kashihara, N; Kidokoro, K; Nagasu, H; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A, 2019) |
| " The current study aimed to investigate the effect of ALA in a rhabdomyolysis-induced mouse model of AKI created by intramuscular injection of 50% glycerol." | 7.91 | 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. ( Itano, S; Kashihara, N; Kidokoro, K; Nagasu, H; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A, 2019) |
| "Rhabdomyolysis-induced AKI was induced by an intramuscular injection of glycerol (5 mL/kg body weight) into mice." | 7.91 | 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. ( Itano, S; Kashihara, N; Kidokoro, K; Nagasu, H; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A, 2019) |
| "Renal ischemia reperfusion injury (IRI) is a major factor responsible for acute renal failure." | 5.39 | 5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury. ( Abe, F; Cai, S; Ding, Q; Fujino, M; Hou, J; Ito, H; Kitajima, Y; Li, XK; Takahashi, K; Tanaka, T, 2013) |
| "5-aminolevulinic acid markedly reduced renal dysfunction and tubular damage in mice with rhabdomyolysis-induced AKI." | 3.91 | 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. ( Itano, S; Kashihara, N; Kidokoro, K; Nagasu, H; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A, 2019) |
| " The current study aimed to investigate the effect of ALA in a rhabdomyolysis-induced mouse model of AKI created by intramuscular injection of 50% glycerol." | 3.91 | 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. ( Itano, S; Kashihara, N; Kidokoro, K; Nagasu, H; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A, 2019) |
| "Rhabdomyolysis-induced AKI was induced by an intramuscular injection of glycerol (5 mL/kg body weight) into mice." | 3.91 | 5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury. ( Itano, S; Kashihara, N; Kidokoro, K; Nagasu, H; Sasaki, T; Satoh, M; Sogawa, Y; Uchida, A, 2019) |
| "Renal ischemia reperfusion injury (IRI) is a major factor responsible for acute renal failure." | 1.39 | 5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury. ( Abe, F; Cai, S; Ding, Q; Fujino, M; Hou, J; Ito, H; Kitajima, Y; Li, XK; Takahashi, K; Tanaka, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uchida, A | 1 |
| Kidokoro, K | 1 |
| Sogawa, Y | 1 |
| Itano, S | 1 |
| Nagasu, H | 1 |
| Satoh, M | 1 |
| Sasaki, T | 1 |
| Kashihara, N | 1 |
| Hou, J | 1 |
| Cai, S | 1 |
| Kitajima, Y | 1 |
| Fujino, M | 1 |
| Ito, H | 1 |
| Takahashi, K | 1 |
| Abe, F | 1 |
| Tanaka, T | 1 |
| Ding, Q | 1 |
| Li, XK | 1 |
| Terada, Y | 1 |
| Inoue, K | 2 |
| Matsumoto, T | 1 |
| Ishihara, M | 1 |
| Hamada, K | 1 |
| Shimamura, Y | 1 |
| Ogata, K | 1 |
| Taniguchi, Y | 1 |
| Horino, T | 1 |
| Karashima, T | 1 |
| Tamura, K | 1 |
| Fukuhara, H | 1 |
| Fujimoto, S | 1 |
| Tsuda, M | 1 |
| Shuin, T | 1 |
3 other studies available for aminolevulinic acid and Acute Kidney Failure
| Article | Year |
|---|---|
5-Aminolevulinic acid exerts renoprotective effect via Nrf2 activation in murine rhabdomyolysis-induced acute kidney injury.
Topics: Acute Kidney Injury; Aminolevulinic Acid; Animals; Antioxidants; Apoptosis; Cells, Cultured; Cytokin | 2019 |
5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury.
Topics: Acute Kidney Injury; Aminolevulinic Acid; Animals; Carbon Monoxide; Cell Death; Drug Evaluation, Pre | 2013 |
5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivo.
Topics: Acute Kidney Injury; Aminolevulinic Acid; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Casp | 2013 |